SciBac

United States · 3 Employees
SciBac creates rEvolutionary live biotherapeutics that treat antibiotic resistant disease while fortifying the microbiome. We improve beneficial microorganisms using our novel platform technology that can quickly, naturally, and safely transfer useful genetic traits. The resulting microorganism has all the best traits to target a specific disease through multiple modes of action and enhance the microbiome for faster recovery and reduced risk of reinfections. By focusing on developing therapies for antibiotic resistant diseases, SciBac fills a rapidly increasing medical need. SciBac's first product targets the nation's biggest antibiotic resistant threat, Clostridium difficile infection. Our microorganism strains out compete C. difficile by stopping colonization, neutralizing toxins, and directly killing the C. difficile organism. Unlike antibiotics, our product only targets C. difficile, allowing the rest of a patient's microbiome to thrive, speeding up patient recovery and lowering the risk of recurrence.

概述

国家 United States
成立时间 2015
总部 1828 el camino real, burlingame, california, united states
电话号码 +1 650-689-5343
网站 http://www.scibac.com
LinkedIn http://www.linkedin.com/company/scibac
Twitter https://twitter.com/SciBacInc
Facebook https://facebook.com/SciBacInc
员工数 3
行业 research,
简介 SciBac creates rEvolutionary live biotherapeutics that treat antibiotic resistant disease while fortifying the microbiome. We improve beneficial microorganisms using our novel platform technology that can quickly, naturally, and safely transfer useful genetic traits. The resulting microorganism has all the best traits to target a specific disease through multiple modes of action and enhance the microbiome for faster recovery and reduced risk of reinfections. By focusing on developing therapies for antibiotic resistant diseases, SciBac fills a rapidly increasing medical need. SciBac's first product targets the nation's biggest antibiotic resistant threat, Clostridium difficile infection. Our microorganism strains out compete C. difficile by stopping colonization, neutralizing toxins, and directly killing the C. difficile organism. Unlike antibiotics, our product only targets C. difficile, allowing the rest of a patient's microbiome to thrive, speeding up patient recovery and lowering the risk of recurrence.

技术

Android

Frameworks and Programming Languages

Gmail

Email Providers

Google Apps

Other

常见问题

SciBac 在哪里?

SciBac 的总部位于 1828 el camino real, burlingame, california, united states

SciBac 的电话号码是多少?

SciBac 的电话号码是 +1 650-689-5343

SciBac 的官方网站是什么?

SciBac 的公司官方网站是 http://www.scibac.com

SciBac 是做什么的?

SciBac 的业务有哪些?

biotechnology,synthetic biology,bio-pharm,therapeutics,life sciences

SciBac 的年收入是多少?

SciBac 的收入是 0美元

SciBac 有多少员工?

SciBac 有 3 名员工

SciBac 属于哪个行业?

SciBac 从事以下行业: research

SciBac 使用什么技术?

SciBac 使用的一些流行技术包括: Android,Gmail,Google Apps

如何联系 SciBac?

SciBac 联系信息: 电话号码:+1 650-689-5343， 网站:http://www.scibac.com， 邮箱：ema***@***.com

SciBac 的社交媒体链接是什么?

SciBac 领英：http://www.linkedin.com/company/scibac,fackbook：https://facebook.com/SciBacInc,twitte:https://twitter.com/SciBacInc

SciBac 是一家上市公司吗?

不是

SciBac 的最后一轮融资是什么时候?

SciBac在2019-07-09T00:00:00.000+00:00结束了最后一轮融资,金额达286.5K$。

谁投资 SciBac?

SciBac 有 2 家投资者,包括 National Institutes of Health、CARB-X。

管理层

Derik Twomey

Co Founder, COO and Cell Biologist

Anthony Cann

Co Founder

员工

Jeanette Mucha

Chief Executive Officer

外贸获客 查找关键决策人

10亿+海关交易数据，1.2亿企业数据，2亿+企业联系人数据，1000千万真实采购商。覆盖200+个国家及地区，95%外贸重点拓展市场，可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少，成就更大，销售更聪明

查找更多 B2B 联系人，丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google